FDA approve trial into CBD capsules as a therapeutic option for opioid addiction

By |2022-01-10T10:58:39+00:0010 January 2022|

The trial is described as a ‘key milestone’ in research examining therapeutic alternatives for opioid use disorder. It is hoped the study will help to reverse the effects of the ongoing opioid epidemic. The US-based research-focused biotech company, Ananda Scientific announced its CBD drug will be part [...]